Your browser does not support iframes.
KC Star Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
DepoMed, Inc.
(NQ:
DEPO
)
5.710
USD
UNCHANGED
Official Closing Price
/ Updated:
8:10 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about DepoMed, Inc.
< Previous
1
2
3
4
5
6
7
8
9
Next >
Depomed To Present At UBS Global Healthcare Conference
May 16, 2013
from
PR Newswire
Depomed Reports First Quarter 2013 Financial Results
May 08, 2013
Conference Call Scheduled for today at 4:30 PM EDT
Read More
from
PR Newswire
Depomed To Report First Quarter Fiscal Year 2013 Financial Results On Wednesday, May 8, 2013
May 01, 2013
from
PR Newswire
Depomed To Present At Roth Capital Partners 25th Annual Growth Stock Conference
March 13, 2013
from
PR Newswire
Bearish Drug Companies - DepomedInc (DEPO), Dynavax Technologies (DVAX), CARDIOME PHARMA (CRME)
March 05, 2013
from
SBWire Direct - Latest Press Releases
Depomed Provides Update on SEFELSA™ FDA Advisory Committee
March 04, 2013
from
PR Newswire
Trading of Depomed Common Stock Halted
March 04, 2013
Advisory Committee of the Food and Drug Administration to Discuss SEFELSA™ New Drug Application for the Treatment of Moderate to Severe Vasomotor Symptoms
Read More
from
PR Newswire
Depomed To Present At Cowen and Company Health Care Conference
February 26, 2013
from
PR Newswire
Depomed Reports Fourth Quarter and Full Year 2012 Financial Results
February 20, 2013
Conference Call Scheduled for today at 4:30 PM EST
Read More
from
PR Newswire
Depomed To Report Fourth Quarter Fiscal Year 2012 Financial Results On Wednesday, February 20, 2013
February 13, 2013
from
PR Newswire
Depomed Announces Appointment of Vicente J. Anido, Jr., Ph.D. to Board of Directors, and Retirement of Directors Julian N. Stern and Craig R. Smith, M.D.
February 11, 2013
from
PR Newswire
EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals
December 28, 2012
from
PR Newswire
Depomed Announces Dismissal Of Suit Against Two Gralise ANDA Filers Following Withdrawal Of ANDA And Patent Challenge
December 26, 2012
from
PR Newswire
Depomed To Present At Oppenheimer 2012 Healthcare Conference
December 03, 2012
from
PR Newswire
Depomed To Present At Piper Jaffray 2012 Healthcare Conference
November 19, 2012
from
PR Newswire
Depomed Reports Top Line Data for Phase 2 Study in Parkinson's Disease
November 07, 2012
from
PR Newswire
Depomed To Present At Lazard 2012 Healthcare Conference
November 06, 2012
from
PR Newswire
Depomed Reports Third Quarter Financial Results
November 05, 2012
Conference Call Scheduled for today at 5:00PM EST
Read More
from
PR Newswire
Depomed To Report Third Quarter Fiscal Year 2012 Financial Results On Monday, November 5, 2012
October 29, 2012
from
PR Newswire
Depomed Announces Serada® NDA Acceptance and FDA Advisory Committee Meeting
October 15, 2012
from
PR Newswire
Depomed, Inc. Appoints Dr. Samuel Saks To Its Board Of Directors
October 09, 2012
from
PR Newswire
Breeze 3 data for Serada® presented at 2012 North American Menopause Society Annual Meeting
October 03, 2012
from
PR Newswire
BREEZE 3 data for Serada® presented at 2012 North American Menopause Society Annual Meeting
October 03, 2012
from
PR Newswire
Depomed Completes Conversion Of Contract Sales Force To Direct Employees
October 02, 2012
from
PR Newswire
Depomed Files Suit Against The FDA Seeking Grant Of Orphan Drug Exclusivity For Gralise® (Gabapentin)
September 25, 2012
from
PR Newswire
Depomed To Present At UBS Global Life Sciences Conference
September 14, 2012
from
PR Newswire
Depomed To Present At Morgan Stanley 2012 Healthcare Conference
September 06, 2012
from
PR Newswire
Depomed To Present At Morgan Stanley 2012 Healthcare Conference
September 06, 2012
from
PR Newswire
Depomed Licenses Acuform® Patents to Janssen Pharmaceuticals, Inc.
August 27, 2012
from
PR Newswire
Depomed To Present At Stifel Nicolaus 2012 Healthcare Conference
August 24, 2012
from
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.